Serotonin/dopamine interaction in learning

Progress in Brain Research

Volumn 172, Issue , 2008, Pages 567-602

  Olvera Cortés, María Esther ^a,b   Anguiano Rodríguez, Patricia ^a   López Vázquez, Miguel Ángel ^a   Alfaro, José Miguel Cervantes ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSIDAD MICHOACANA DE SAN NICOLÁS DE HIDALGO   (Mexico)

Author keywords

cognition; dopamine receptors; learning; Parkinson's disease; prefrontal cortex; serotonin; striatum

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 3 (1 ADAMANTYL) 1 AMINOMETHYL 3,4 DIHYDRO 5,6 DIHYDROXY 1H 2 BENZOPYRAN; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 METHYL 2,5 DIMETHOXYAMPHETAMINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; DOPAMINE; DOPAMINE RECEPTOR; LEVODOPA; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RO 4368554; ROBALZOTAN; SEROTONIN; SEROTONIN 4 AGONIST; SEROTONIN 6 ANTAGONIST; SEROTONIN RECEPTOR; SL 65 0155; UNCLASSIFIED DRUG; VOLINANSERIN;

BEHAVIOR DISORDER; COGNITIVE DEFECT; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; EXCITATORY POSTSYNAPTIC POTENTIAL; HUMAN; INHIBITORY POSTSYNAPTIC POTENTIAL; LEARNING; LONG TERM MEMORY; MAZE TEST; MENTAL DISEASE; MOOD DISORDER; MOTOR DYSFUNCTION; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PASSIVE AVOIDANCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; SHORT TERM MEMORY; WORKING MEMORY;

ANIMALS; BEHAVIOR, ANIMAL; COGNITION; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; HUMANS; LEARNING; MEMORY; NEURONS; PREFRONTAL CORTEX; PROTEIN ISOFORMS; RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGENTS; SYNAPTIC TRANSMISSION;

EID: 50349098974     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)00927-8     Document Type: Review

References (308)

1. Abi-Dargham A., Mawlawi O., Lombardo I., Gil R., Martinez D., Huang Y., Hwang D.R., Keilp J., Kochan L., Van Heertum R., Gorman J.M., and Laruelle M. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J. Neurosci. 22 9 (2002) 3708-3719
2. Able J.A., Gudelsky G.A., Vorhees C.V., and Williams M.T. 3,4-methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory. Biol. Psychiatry 59 12 (2006) 1219-1226
3. Abrahams B.S., Rutheford J.D., Mallet P.E., and Beninger R.J. Place conditioning with the dopamine D1-like receptor agonist SKF 8295 but not SKF 81297 or SKF 77434. Eur. J. Pharmacol. 343 2-3 (1998) 111-118
4. Afifi A., and Kaelber W.W. Efferent connections of the substantia nigra in the cat. Exp. Neurol. 11 (1965) 474-482
5. Alex K.D., and Pehek E.A. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol. Ther. 113 2 (2007) 296-320
6. Alex K.D., Yavanian G.J., McFarlane H.G., Pluto C.P., and Pehek E.A. Modulation of dopamine release by striatal 5-HT2C receptors. Synapse 55 4 (2005) 242-251
7. Allan A.M., Galindo R., Chynowet J., Engel S.R., and Savage D.D. Conditioned place preference for cocaine is attenuated in mice over-expressing the 5-HT(3) receptor. Psychopharmacol. (Berl.) 158 1 (2001) 18-27
8. Altman H.J., Normile H.J., Galloway M.P., Ramirez A., and Azmitia E.C. Enhanced spatial discrimination learning in rats following 5,7-DHT-induced serotonergic deafferentation of the hippocampus. Brain Res. 518 1-2 (1990) 61-66
9. Amaral D.G., and Price J.L. Amygdalo-cortical projections in the monkey (Macaca fascicularis). J. Comp. Neurol. 230 4 (1984) 465-496
10. Anguiano-Rodríguez P., Gaytán.Tocavén L., and Olvera-Cortés M.E. Striatal serotonin depletion facilitates rat egocentric learning via dopamine modulation. Eur. J. Pharmacol. 556 1-3 (2007) 91-98
11. Araki T., Yamasue H., Sumiyoshi T., Kuwabara H., Suga M., Iwanami A., Kato N., and Kasai K. Perospirone in the treatment of schizophrenia: effect on verbal memory organization. Progr. Neuropsychopharmacol. Biol. Psychiatry 30 2 (2006) 204-208
12. Arvanov V.L., Liang X., Magro P., Roberts S., and Wang R.Y. A pre- and post-synaptic modulatory action of 5-HT and 5-HT2A, 2C receptor agonist DOB on NMDA-evoked responses in the rat medial prefrontal cortex. Eur. J. Neurosci. 11 8 (1999) 2917-2934
13. Asin K.E., and Fibiger H.C. Spontaneous and delayed spatial alternation following damage to specific neuronal elements within the nucleus medianus raphe. Behav. Brain. Res. 13 3 (1984) 241-250
14. Assié, M.B., Ravhaile, V., Faucillon, V., Newman-Tancredi, A. (2005) Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain. 315(1): 265-272.
15. Aultman J.M., and Moghaddam B. Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task. Psychopharmacol. (Berl.) 153 3 (2001) 353-364
16. Azmitia E.C., and Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol. 179 3 (1978) 641-667
17. Badgaiyan R.D., Fischman A.J., and Alpert N.M. Striatal dopamine release in sequential learning. Neuroimage 38 3 (2007) 549-556
18. Bandelow B., and Meier A. Aripiprazole, a "dopamine-serotonin system stabilizer" in the treatment of psychosis. Ger. J. Psychiatry 6 1 (2003) 9-16
19. Barbas H., and De Olmos J. Projections from the amygdala to basoventral and mediodorsal prefrontal regions in the rhesus monkey. J. Comp. Neurol. 300 4 (1990) 549-571
20. Barbas H., and Pandya D.N. Architecture and intrinsic connections of the prefrontal cortex in the rhesus monkey. J. Comp. Neurol. 286 3 (1989) 353-375
21. Barnes J.M., Costall B., Coughlan J., Domeney A.M., Gerrard P.A., Kelly M.E., Naylor R.J., Onaivi E.S., Tomkins D.M., and Tyers M.B. The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates. Pharmacol. Biochem. Behav. 35 4 (1990) 955-962
22. Barnes N.M., and Sharp T. A review of central 5-HTreceptors and their function. Neuropharmacology 38 8 (1999) 1083-1152
23. Beart P.M., and McDonald D. 5-Hydroxytryptamine 5-hydroxytryptaminergic-dopaminergic interactions in the ventral area of rat brain. J. Pharm. Pharmacol. 34 9 (1982) 591-593
24. Béïque J.C., Imad M., Mladenovic L., Gingrich J.A., and Andrade R. Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex. Proc. Natl. Acad. Sci. U.S.A. 104 23 (2007) 9870-9875
25. Bersani G., Grispini A., Marini S., Pasini A., Valducci M., and Ciani N. 5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo. Clin. Neuropharmacol. 13 6 (1990) 500-506
26. Biggio G., Fadda F., Fanni P., Tagliamonte A., and Gessa G.L. Rapid depletion of serum tryptophan, brain tryptophan, serotonin and 5-hydroxyindoleacetic acid by a tryptophan-free diet. Life Sci. 14 7 (1974) 1321-1329
27. Blackburn T.P., Minabe Y., Middlemiss D.N., Shirayama Y., Hashimoto K., and Ashby Jr. C.R. Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study. Synapse 46 3 (2002) 129-139
28. Blandina P., Goldfarb J., Craddock-Royal B., and Green J.P. Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum. J. Pharmacol. Exp. Ther. 251 3 (1989) 803-809
29. Booij L., Van der Does A.J., and Riedel W.J. Monoamine depletion in psychiatric and healthy populations. Mol. Psychiatry 8 12 (2003) 951-973
30. Boulougouris V., Glennon J.C., and Robbins T.W. Dissociable effects of selective 5-HT2(A) and 5-HT2(C) receptor antagonists on serial spatial reversal learning in rats. Neuropsychopharmacology 33 2 (2008) 2007-2019
31. Bourson A., Boess F.G., Bös M., and Sleight A.J. Involvement of 5-HT6 receptors in nigro-striatal function in rodents. Br. J. Pharmacol. 125 7 (1998) 1562-1566
32. Bouthenet M.L., Martres M.P., Sales N., and Schwartz J.C. A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride. Neuroscience 20 1 (1987) 117-155
33. Brasted P.J., Humby T., Dunnett S.B., and Robbins T.W. Unilateral lesions of the dorsal striatum in rats disrupt responding in egocentric space. J. Neurosci. 17 22 (1997) 8919-8926
34. Briand L.A., Gritton H., Howe W.M., Young D.A., and Sarter M. Modulators in concert for cognition: modulator interactions in the prefrontal cortex. Prog. Neurobiol. 83 2 (2007) 69-91
35. Brodmann K. Vergleichende lokalisationslehre der grosshinhinde (1909), Barth, Leipzig
36. Buhot M.C. Serotonin receptors in cognitive behaviors. Curr. Opin. Neurobiol. 7 2 (1997) 243-254
37. Buhot M.C., Martin S., and Segu L. Role of serotoinin in memory impairment. Ann. Med. 31 3 (2000) 210-221
38. Buhot M.C., Patra S.K., and Naïli S. Spatial memory deficits following stimulation of hippocampal 5-HT1B receptors in the rat. Eur. J. Pharmacol. 285 3 (1995) 218-221
39. Bubser M., and Schmidt W.J. 6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze. Behav. Brain Res. 37 2 (1990) 157-168
40. Calabresi P., Pisani A., Mercuri N.B., and Bernardi G. Long-term potentiation in the striatum is unmasked by removing the voltage-dependent blockade of NMDA receptor channel. Eur. J. Neurosci. 4 10 (1992) 929-935
41. Campbell A.D., Kohl R.R., and McBride W.J. Serotonin-3 receptor and ethanol-stimulated somatodendritic dopamine release. Alcohol 13 6 (1996) 569-574
42. Carbon M.A., Ma Y., Barnes A., Dhawan V., Chaly T., Ghilardi M.F., and Eidelberg D. Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism. Neuroimage 21 4 (2004) 1497-1507
43. Carli M., Luschi R., Garofalo P., and Samanin R. 8-OH-DPAT impairs spatial but not visual learning in a water maze by stimulating 5-HT1A receptors in the hippocampus. Behav. Brain Res. 67 1 (1995) 67-74
44. Carli M., Silva S., Balducci C., and Samanin R. WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by blockade of hippocampal NMDA receptors. Neuropharmacology 38 8 (1999) 1165-1173
45. Carta M., Carlsson T., Kirik D., and Bjökund A. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain 130 7 (2007) 1819-1833
46. Castellano C., Cestari V., Cabib S., and Puglisi-Allegra S. Post-training dopamine receptor agonists and antagonists affect memory storage in mice irrespective of their selectivity for D1 and D2 receptors. Behav. Neural. Biol. 56 3 (1991) 283-291
47. Castro M.E., Pascual J., Romon T., Bercianno J., Figols J., and Pazos A. 5-HT1B receptor binding in degenerative movement disorders. Brain Res. 790 1-2 (1998) 323-328
48. Celada P., Puig M.V., Casanovas J.M., Guillazo G., and Artigas F. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A), and glutamate receptors. J. Neurosci. 21 24 (2001) 9917-9929
49. Chapman D.E., Hanson G.R., Kesner R.P., and Keefe K.A. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine. J. Pharmacol. Exp. Ther. 296 2 (2001) 520-527
50. Chen G., Greengard P., and Yan Z. Potentiation of NMDA receptor currents by dopamine D1 receptors in prefrontal cortex. Proc. Natl. Acad. Sci. U.S.A. 101 8 (2004) 2596-2600
51. Cheng A.V., Ferrier I.N., Morris C.M., Jabeen S., Shagal A., McKeith I.G., Edwardson J.A., Pery R.H., and Perry E.K. Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases. J. Neurol. Sci. 106 1 (1991) 50-55
52. Chinaglia G., Landwehrmeyer B., Probst A., and Palacios J.M. Serotoninergic terminal transporters are differentially affected in Parkinson's disease and progressive nuclear palsy: an autoradiographic study with [3H]citalopram. Neuroscience 54 3 (1993) 691-699
53. Cimadevilla J.M., Wesierska M., Fenton A.A., and Bures J. Inactivating one hippocampus impairs avoidance of a stable room-defined place during dissociation of arena cues from room cues by rotation of the arena. Proc. Natl. Acad. Sci. U.S.A. 98 6 (2001) 3531-3536
54. Clarke H.F., Dalley J.W., Crofts H.S., Robbins T.W., and Roberts A.C. Cognitive inflexibility after prefrontal serotonin depletion. Science 304 5672 (2004) 878-880
55. Clarke H.F., Walker S.C., Crofts H.S., Dalley J.W., Robbins T.W., and Robertsm A.C. Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J. Neurosci. 25 2 (2005) 532-538
56. Colado M.I., O'Shea E., and Green A.R. Acute and long-term effects of NDMA on cerebral dopamine biochemistry and function. Psychopharmacology 173 3-4 (2004) 249-263
57. Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson′s disease. Neurosci. Biobehav. Rev. 30 1 (2006) 1-23
58. Daberkow D.P., Kesner R.P., and Keefe K.A. Relation between methamphetamine-induced monoamine depletions in the striatum and sequential motor learning. Pharmacol. Biochem. Behav. 81 1 (2005) 198-204
59. Dauer W., and Przedborski S. Parkinson disease: mechanisms and models. Neuron 39 6 (2003) 889-909
60. Daw N.D., Kakade S., and Dayan P. Opponent interactions between serotonin and dopamine. Neural Netw. 15 4-6 (2002) 603-616
61. Dawson L.A., Nguyen H.Q., and Li P. Potentiation of amphetamine-induced changes in dopamine and 5-HT by a 5-HT(6) receptor antagonist. Brain Res. Bull. 59 6 (2003) 513-521
62. De Belleroche J.S., and Bradford H.F. Presynaptic control of the synthesis and release of dopamine from striatal synaptosomes: a comparison between the effects of 5-hydroxytryptamine, acetylcholine, and glutamate. J. Neurochem. 35 5 (1980) 1227-1234
63. DeCoteau W.E., and Kesner R.P. A double dissociation between the rat hippocampus and medial caudoputamen in processing two forms of knowledge. Behav. Neurosci. 114 6 (2000) 1096-1108
64. De la Fuente-Fernandez R., Sois V., Huang Z., Furatado S., Lu J.Q., Calne D.B., Ruth T.J., and Stoessl A.J. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. Brain 127 pt. 12 (2004) 2747-2754
65. De Simoni M.G., Dal Toso G., Fodritto F., Sokola A., and Algeri S. Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotonergic afferences. Brain Res. 411 1 (1987) 81-88
66. Díaz-Mataix L., Scorza M.C., Bortolozzi A., Toth M., Celada P., and Artigas F. Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action. J. Neurosci. 25 47 (2005) 10831-10843
67. Di Giovanni G., De Dewaerdére P., Di Mascio M., Di Matteo V., Esposito E., and Spampinato U. Selective blockade of serotonin-2B/2C receptors enhances mesolimbic and mesostriatal dopaminergic function: A combined in vivoelectrophysiological and microdialisys study. Neuroscience 91 2 (1999) 587-597
68. Di Giovanni G., Di Matteo V., Di Mascio M., and Esposito E. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study. Synapse 35 1 (2000) 53-61
69. Di Giovanni G., Di Matteo V., Pierucci M., Benigno A., and Espósito E. Serotonin involvement in the basal ganglia pathophysiology: could the 5-HT2C receptor be a new target for therapeutic strategies?. Curr. Med. Chem. 13 25 (2006) 3069-3081
70. Di Matteo V., Di Giovanni G., Di Mascio M., and Espósito E. Selective blockade of serotonin 2C/2B receptors enhances dopamine release in the rat nucleus accumbens. Neuropharmacology 37 2 (1998) 265-272
71. Di Matteo V., Di Giovanni G., Di Mascio M., and Espósito E. Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin (2C) receptors. Brain Res. 865 1 (2000) 85-90
72. Di Matteo V., Pierucci M., and Espósito E. Selective stimulation of seotonin 2c receptors blocks the enhancement of strital and accumbal dopamine release induced by nicotina. J. Neurochem. 89 2 (2004) 418-429
73. Di Pietro N.C., and Seamans J.K. Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action. Pharmacopsychiatry 40 Suppl. 1 (2007) S27-S33
74. Dunnett S.B., and White A. Striatal grafts alleviate bilateral striatal lesion deficits in operant delayed alternation in the rat. Exp. Neurol. 199 2 (2006) 479-489
75. Durif F., Debilly B., Galitzky M., Morand D., Viallet F., Borg M., Thobois S., Broussolle E., and Rascol O. Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study. Neurology 62 3 (2004) 381-388
76. Durstewitz D., and Seamans J.K. The computational role of dopamine D1 receptors in working memory. Neural Netw. 15 4-6 (2002) 561-572
77. Durstewitz D., and Seamans J.K. The computational role of dopamine D1 receptors in working memory. Neural Netw. 15 4-6 (2006) 561-572
78. Egashira N., Yano A., Ishigami N., Mishima K., Iwasaki K., Fujioka M., Matsushita M., Nishimura R., and Fujiwara M. Investigation of mechanisms mediating 8-OH-DPAT-induced impairment of spatial memory: involvement of 5-HT1A receptors in the dorsal hippocampus of rats. Brain Res. 1069 1 (2006) 54-62
79. Eglen R.M., Jasper J.R., Chang D.J., and Martin G.R. The 5-HT7 receptor: orphan found. Trends. Pharmacol. Sci. 18 4 (1997) 104-107
80. Eglen R.M., Wong E.H., Dumius A., and Bockaert J. Central 5-HT4 receptors. Trends Pharmacol. Sci. 16 11 (1995) 391-398
81. Faure A., Haberland U., Condé F., and Massioui N.E. Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation. J. Neurosci. 25 11 (2005) 2771-2780
82. Featherstone R.E., and McDonald R.J. Dorsal striatum and stimulus-response learning: lesions of the dorsolateral, but not dorsomedial, striatum impair acquisition of a simple discrimination task. Behav. Brain. Res. 150 1-2 (2004) 15-23
83. Fernández-Pérez S., Pache D.M., and Sewell R.D. Co-administration of fluoxetine and WAY100635 improves short-term memory function. Eur. J. Pharmacol. 522 1-3 (2005) 78-83
84. Ferré S., Cortés R., and Artigas F. Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats. J. Neurosci. 14 8 (1994) 4839-4846
85. Finlay J.M., Zigmond M.J., and Abercrombie E.D. Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience 64 3 (1995) 619-628
86. Fino E., Glowinski J., and Venance L. Bidirectional activity-dependent plasticity at corticostriatal synapses. J. Neurosci. 25 49 (2005) 11279-11287
87. Fletcher P.J., Korth K.M., and Chambers J.W. Selective destruction of brain serotonin neurons by 5,7-dihydroxytryptamine increases responding for a conditioned reward. Psychopharmacol. (Berl.) 147 3 (1999) 291-299
88. Florio T., Capozzo A., Nisini A., Lupi A., and Scarnati E. Dopamine denervation of specific striatal sub-regions differentially affects preparation and execution of delayed response task in the rat. Behav. Brain. Res. 104 1-2 (1999) 51-62
89. Fluxe K., Hökfelt T., Johansson O., Jonsson G., Lidbrink P., and Ljungdahl A. The origin of the dopamine nerve terminals in limbic and frontal cortex: evidence for meso-cortico dopamine neurons. Brain Res. 82 2 (1974) 349-355
90. Fox S.H., and Brotchie J.M. 5-HT2C receptor binding is increased in the substantia nigra pars reticulate in Parkinson's disease. Mov. Disord. 15 6 (2000) 1064-1069
91. Fox S.H., and Brotchie J.M. 5-HT(2C) receptor antagonists enhance the behavioural response to dopamine D(1) receptor agonists in the 6-hydroxydopamine-lesioned rat. Eur. J. Pharmacol. 398 1 (2000) 59-64
92. Frantz K.J., Hansson K.J., Stouffer D.G., and Parsons L.H. 5-HT6 receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine. Neuropharmacology 42 2 (2002) 170-180
93. Fuster J. The Prefrontal Cortex (1980), Raven, New York
94. rd edn. (1997), Lippincott-Raven, Philadelphia
95. Fuster J.M. The prefrontal cortex- an update: time is of the essence. Neuron 30 2 (2001) 319-333
96. Galeotti N., Gheraldini C., and Bartolini A. Role of 5-HT4 receptors in the mouse passive avoidance test. J. Pharmacol. Exp. Ther. 286 3 (1998) 1115-1121
97. Gallagher P., Massey A.E., Young A.E., et al. Effects of acute tryptophan depletion on executive function in healthy male volunteers. Psychiatry 3 (2003) 1-9
98. Gasbairri, A., Cifariello, A., Pompili, A. and Meneses, A. (2008) Effect of 5-HT(7) antagonist SB-269970 in the modulation of working and reference memory in the rat. Behav. Brain Res., doi:10.1016/j.bbr.2007.12.020.
99. Gerard C., Martres M.P., Lefevre K., Miquel M.C., Verge D., Lanfumey L., Doucet E., Hamon M., and el Mestikawy S. Immuno-localizationof serotonin 5-HT6 receptor-like material in the rat central nervous system. Brain Res. 764 1-2 (1997) 207-219
100. Gervais J., and Rouillard C. Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra. Synapse 35 4 (2000) 281-291
101. Geyer M.A., Puerto A., Dawsey W.J., Knapp S., Bullard W.P., and Mandell A.J. Histologic and enzymatic studies of the mesolimbic and mesostriatal serotonergic pathways. Brain Res. 106 2 (1976) 241-256
102. Gobert A., and Millan M.J. Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats. Neuropharmacology 38 2 (1999) 315-317
103. Gobert A., Rivet J.M., Lejeune F., Newman-Tancredi A., Adhumeau-Auclair A., Nicolas J.P., Cistarelli L., Melon C., and Millan M.J. Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 36 3 (2000) 205-221
104. Goldman-Rakic P.S. Circuitry of Primate Prefrontal Cortex and Regulation of Behavior by Representational Memory (1987), American Physiological Behavior, Bethesda
105. Goldman-Rakic P.S. Cellular basis of working memory. Neuron 14 3 (1995) 477-485
106. Goldman-Rakic P.S., Lidow M.S., and Gallager D.W. Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex. J. Neurosci. 10 7 (1990) 2125-2138
107. Goldman-Rakic P.S., Muly III E.C., and Williams G.V. D(1) receptors in prefrontal cells and circuits. Brain Res. Rev. 31 2-3 (2000) 295-301
108. Goldman-Rakic P.S., and Schwartz M.L. Interdigitation of contralateral and ipsilateral columnar projections to frontal association cortex in primates. Science 216 4547 (1982) 755-757
109. González-Burgos G., Kroener S., Seamans J.K., Lewis D.A., and Barrionuevo G. Dopaminergic modulation of short-term synaptic plasticity in fast-spiking interneurons of primate dorsolateral prefrontal cortex. J. Neurophysiol. 94 6 (2005) 4168-4177
110. González-Burgos I., Pérez-Vega M.I., Del Angel-Meza A.R., and Feria-Velasco A. Effect of tryptophan restriction on short-term memory. Physiol. Behav. 63 2 (1998) 165-169
111. Gorelova N., Seamans J.K., and Yang C.R. Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex. J. Neurophysiol. 88 6 (2002) 3150-3166
112. Gorelova N., and Yang C.R. Dopamine D1/D5 receptor activation modulates a persistent sodium current in rat prefrontal cortical neurons in vitro. J. Neurophysiol. 84 1 (2000) 75-87
113. Gouzoulis-Mayfrank E., Daumann J., Tutchenhagen F., Pelz S., Becker S., Kunert H.-J., Fimm B., and Sass H. Impaired cognitive performance in drug free users of recreational ecstasy (NDMA). J. Neurol. Neurosurg. Psychiatry 68 6 (2000) 719-725
114. Gouzoulis-Mayfrank E., Thimm B., Rezk M., Hensen G., and Daumann J. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 5 (2003) 819-827
115. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41 1 (1991) 1-24
116. Grace A.A. The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction 95 Suppl. 2 (2000) S119-S128
117. Gray J.A., and Roth B.L. Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophr. Bull. 5 (2007) 1100-1119
118. Graybiel A.M., Hirsch E.C., and Agid Y. The nigrostriatal system in Parkinson's disease. Adv. Neurol. 153 (1990) 17-29
119. Green A.R., Mechan A.O., Elliot M., O′Shea E., and Colado M.I. The pharmacology and clinical pharmacology of 3-4-methylenedioxymethamphetamine (NDMA, 'Ecstasy'). Pharmacol. Rev. 55 3 (2003) 463-508
120. Groenewegen H.J., and Uylings H.B. The prefrontal cortex and the integration of sensory, limbic and autonomic information. Prog. Brain Res. 126 (2000) 3-28
121. Gu Q. Neuromodulatory transmitter systems in the cortex and their role in cortical plasticity. Neuroscience 111 4 (2002) 815-835
122. Guttman M., Boileau I., Warsh J., Saint-Cyr J.A., Ginovart N., McCluskey T., Houle S., Wilson A., Mundo E., Rusjan P., Meyer J., and Kish S.J. Brain serotonin transporter binding in non-depressed patients with Parkinson's disease. Eur. J. Neurol. 14 5 (2007) 523-528
123. Haapaniemi T.H., Ahonen A., Torniainen P., Sotaniemi K.A., and Myllylä V.V. [1231] Beta-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients. Mov. Disord. 16 1 (2001) 124-130
124. Halliday G.M., Blumbergs P.C., Cotton R.G.H., Blesing W.W., and Geffen L.B. Loss of brainstem serotonin and substance P-containing neurons in Parkinson's disease. Brain Res. 510 1 (1990) 104-107
125. Harrell A.V., and Allan A.M. Improvements in hippocampal-dependent learning and decremental attention in 5-HT(3) receptor overexpressing mice. Learn. Mem. 10 5 (2003) 410-419
126. Harrison A.A., Everitt B.J., and Robbins T.W. Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacol. (Berl.) 133 4 (1997) 329-342
127. Harrison A.A., Everitt E.J., and Robbins T.W. Central serotonin depletion impairs both the acquisition and performance of a symmetrically reinforced go/no-go conditional visual discrimination. Behav. Brain. Res. 100 1-2 (1999) 99-112
128. Harvey J.A. Serotonergic regulation of associative learning. Behav. Brain Res. 73 1-2 (1996) 47-50
129. Hervé D., Simon H., Blanc G., Lisoprawski A., Le Moal M., Glowinski J., and Tassin J.P. Increased utilization of dopamine in the nucleus accumbens but not in the cerebral cortex after dorsal raphe lesion in the rat. Neurosci. Lett. 15 2-3 (1979) 127-133
130. Hong E., and Meneses A. Systemic injection of p-chloroamphetamine eliminates the effect of the 5-HT3 compounds on learning. Pharmacol. Biochem. Behav. 53 4 (1996) 765-769
131. Hoshi R., Mullins K., Boundy C., Brignell C., Piccini P., and Curran H.V. Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls. Psychopharmacol. (Berl.) 194 3 (2007) 371-379
132. Hritcu L., Clicinschi M., and Nabeshima T. Brain serotonin depletion impairs short-term memory, but not long-term memory in rats. Physiol. Behav. 91 5 (2007) 652-657
133. Hudzik T.J., Howell A., Georger M.M., and Cross A.J. Disruption of acquisition and performance of operant response-duration differentiation by unilateral nigrostriatal lesions. Behav. Brain Res. 114 1-2 (2000) 65-77
134. Hughes J.H., Galllagher P., Stewart M.E., Mattheus D., Kelly T.P., and Young A.H. The effects of acute tryptophan depletion on neuropsychological function. J. Psychopharmacol. 17 3 (2003) 300-309
135. Hutson P.H., Barton C.L., Jay M., Blurton P., Burkamp F., Clarkson R., and Bristow L.J. Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies. Neuropharmacology 39 12 (2000) 2318-2328
136. Ichikawa J., Ishii H., Bonaccorso S., Fowler W.L., O'Laughlin I.A., and Meltzer H.Y. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J. Neurochem. 76 5 (2001) 1521-1531
137. Ikemoto S., and Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res. Brain Res. Rev. 31 1 (1999) 6-41
138. Inoue T., Izumi T., Maki Y., Muraki I., and Koyama T. Effect of dopamine D(1/5) antagonist SCH 23390 on the acquisition of conditioned fear. Pharmacol. Biochem. Behav. 66 3 (2000) 573-578
139. Iravani M.M., Jackson M.J., Kuoppamäki M., Smith L.A., and Jenner P. 3,4-methylenedioxyamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates. J. Neurosci. 23 (2003) 9107-9115
140. Isayama S., Sugimoto Y., Nishiga M., and Kamei C. Effects of histidine on working memory déficits induced by 5-HT1A receptor agonist 8-OH-DPAT. Jpn. J. Pharmacol. 86 4 (2001) 451-453
141. Iyer R.N., and Bradberry C.W. Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization. J. Pharmacol. Exp. Ther. 277 1 (1996) 40-47
142. Iversen S.D. 5-HT and anxiety. Neuropharmacology 23 12B (1984) 1553-1560
143. Iwakawa M., Terao T., Soya A., Kojima H., Inoue Y., Ueda N., Yoshimura R., and Nakamura J. A novel antipsychotic, prospirone, has antiserotonergic and antidopaminergic effects in human brain: findings from neuroendocrine challenge tests. Psychopharmacology 176 3-4 (2004) 407-411
144. Jacobs B.L., and Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 72 1 (1992) 165-229
145. Jacobs B.L., and Fornal C.A. 5-HT and motor control: a hypothesis. Trends Neurosci. 16 1 (1993) 346-352
146. Jakab R.L., and Goldman-Rakic P.S. Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex. J. Comp. Neurol. 417 3 (2000) 337-348
147. Jay T.M. Dopamine: a potential substrate for synaptic plasticity and memory mechanisms. Prog. Neurobiol. 69 6 (2003) 375-390
148. Kaczmarek L.K., and Levitan I.B. Neuromodulation: the biochemical control of neuronal excitability (1987), Oxford University Press, New York
149. Kalén P., Skagerberg G., and Lindvall O. Projections from the ventral tegmental area and mesencephalic raphe to the dorsal raphe nucleus in the rat: evidence for a minor dopaminergic component. Exp. Brain. Res. 73 1 (1988) 69-77
150. Kapur S., and Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am. J. Psychiatry 153 4 (1996) 466-476
151. Katz P.S. What are we talking about? modes of neuronal communication. In: Katz P.S. (Ed). Beyond Neurotransmission (1999), Oxford University Press, New York 1-28
152. Kebabian J.W., Beaulieu M., and Itoh Y. Pharmacological and biochemical evidence for the existence of two categories of dopamine receptor. Can. J. Neurol. Sci. 11 Suppl. 1 (1984) 114-117
153. Kelland M.D., Freeman A.S., and Chiodo L.A. Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons. J. Pharmacol. Exp. Ther. 253 2 (1990) 803-811
154. Kellendon C., Simposn E.H., Polan H.J., Malleret G., Vronskaya S., Winiger V., Moore H., and Kandel E.R. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49 4 (2006) 603-615
155. Kerenyi L., Ticaurte G.A., Schretlen D.J., McCann U., Varga J., Matheus W.B., Ravert H.T., Dannals R.F., Hilton J., Wong D.F., and Szabo Z. Positron emission tomography of striatal serotonin transporters in Parkinson's disease. Arch. Neurol. 60 9 (2003) 1223-1229
156. Kim S.E., Choi J.Y., Choe Y.S., Choi Y., and Lee W.Y. Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 1231-beta-CIT SPECT. J. Nucl. Med. 44 6 (2003) 870-876
157. Kinney J.W., Starosta G., and Crawley J.N. Central galanin administration blocks consolidation of spatial learning. Neurobiol. Learn. Mem. 80 1 (2003) 42-54
158. Kirkby R.J., and Polgar S. Active avoidance in the laboratory rat following lesions of the dorsal or ventral caudate nucleus. Physiol. Psychol. 2 (1974) 301-306
159. Kish S.J. Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?. Adv. Neurol. 91 1 (2003) 39-49
160. Kish S.J., Tong J., Hornykiewicz O., Rajput A., Chang L.J., Guttman M., and Furukawa Y. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain 131 1 (2008) 120-131
161. Kiyatkin E.A., and Rebec G.V. Striatal neuronal activity and responsiveness to dopamine and glutamate after selective blockade of D1 and D2 dopamine receptors in freely moving rats. J. Neurosci. 19 9 (1999) 3594-3609
162. Kostrzewa R., Nowak P., Kostrzewa J., Kostrzewa R., and Brus R. Peculiarities of L-DOPA: treatment of Parkinson's disease. Amino Acids 28 2 (2005) 157-164
163. Kuhn W., Muller T., Gerlach M., Sofic E., Fuchs G., Heye N., Prautsch R., and Przuntek H. Depression in Parkinson's disease: biogenic amines in CSF of "de novo" patients. J. Neural Transm. 103 12 (1996) 1441-1445
164. Kupfermann I. Modulatory actions of neurotransmitters. Ann. Rev. Neurosci. 2 (1979) 447-465
165. Latgen M., Elvander E., Madjid N., and Ogren S.O. Analyses of the role of 5-HT1A receptors in spatial and aversive learning in the rat. Neuropsychopharmacology 48 6 (2005) 830-852
166. Lee E.H., and Geyer M.A. Dopamine autoreceptor mediation of the effects of apomorphine on serotonin neurons. Pharmacol. Biochem. Behav. 21 2 (1984) 301-311
167. Lehmann O., Bertrand F., Jeltsch H., Morer M., Lazarus C., Will B., and Cassel J.C. 5,7-DHT-induced hippocampal 5-HT depletion attenuates behavioural deficits produced by 192 IgG-saporin lesions of septal cholinergic neurons in the rat. Eur. J. Neurosci. 15 12 (2002) 1991-2006
168. Lemon N., and Manahan-Vaughan D. Dopamine D1/D5 receptors gate the acquisition of novel information through hippocampal long-term potentiation and long-term depression. J. Neurosci. 26 29 (2006) 7723-7729
169. Lewis S.J., Slabosz A., Robbins T.W., Barker R.A., and Owen A.M. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease. Neuropsychologia 43 6 (2005) 823-832
170. Liao R.M., Lai W.S., and Lin J.Y. The role of catecholamines in retention performance of a partially baited radial eight-arm maze for rats. Chin. J. Physiol. 45 4 (2002) 177-185
171. Lucas G., Di Matteo V., De Deurwaerdère P., Porras G., Martín-Ruiz R., Artigas F., Esposito E., and Spampinato U. Neurochemical and electrophysiological evidence that 5-HT4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function. Eur. J. Neurosci. 13 5 (2001) 889-898
172. MacDermott A.B., Role L.W., and Siegelbaum S.A. Presynaptic ionotropic receptors and the control of transmitter release. Annu. Rev. Neurosci. 22 (1999) 443-485
173. McDonald R.J., and White N.M. A triple dissociation of memory systems: hippocampus, amygdale, and dorsal striatum. Behav. Neurosci. 107 1 (1993) 3-22
174. Maeda T., Nagata K., Yoshida Y., and Kannary K. Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered L-DOPA. Brain Res. 1046 1-2 (2005) 230-233
175. Mamo D., Graff A., Mizrahi R., Shammi C.M., Romeyer F., and Kapur S. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study. Am. J. Psychiatry 164 9 (2007) 141-147
176. Matsuda T., Sakaue M., Ago Y., Sakamoto Y., Koyama Y., and Baba A. Functional alteration of brain dopaminergic system in isolated aggressive mice. Nihon Shinkei Seishin Yakurigaku Zasshi. 21 3 (2001) 71-76
177. Matsumoto M., Togashi H., Mori K., Ueno K., Miyamoto A., and Yoshioka M. Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex. Eur. J. Pharmacol. 383 1 (1999) 39-48
178. Mayeux R. The serotonin hypothesis for depression and Parkinson's disease. Adv. Neurol. 53 1 (1990) 163-166
179. Mayeux R., Stern Y., Cote L., and Williams J.B. Altered serotonin metabolism in depressed patients with Parkinson's disease. Neurology 34 5 (1984) 642-646
180. McDonald R.J., and White M.N. Parallel information processing in the water maze: evidence for independent memory systems involving dorsal striatum and hippocampus. Behav. Neural. Biol. 61 3 (1994) 260-270
181. McDonald R.J., and White M.N. Hippocampal and non hippocampal contributions to place learning in rats. Behav. Neurosci. 109 4 (1996) 579-593
182. Meltzer H.Y., Li Z., Kaneda Y., and Ichikawa J. Serotonin receptors: their key role in drugs to treat schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 7 (2003) 1159-1172
183. Meneses A. Stimulation of 5-HT1A, 5-HT1B, 5-HT2A/2C, 5-HT3, and 5-HT4 receptors or 5-HT uptake inhibition: short- and long-term memory. Behav. Brain Res. 184 1 (2007) 81-90
184. Meneses, A., Pérez-García, G., Liy-Salmeron, G., Flores-Galvez, D., Castillo, C. and Castillo, E. (2008) The effects of 5-HT(6) receptor agonist EMD and 5-HT(7) receptor agonist AS19 on memory formation. Behav. Brain Res., doi:10.1016/j.bbr.2007.11.023.
185. Micale V., Leggio G.M., Mazzola C., and Drago F.C. Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia. Brain Res. 1121 1 (2006) 207-215
186. Millan M.J. Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors. J. Pharmacol. Exp. Ther. 295 3 (2000) 853-861
187. Millan M.J., Dekeyene A., and Gobert A. Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT release in the frontal cortex in vivo. Neuropharmacology 37 7 (1998) 953-955
188. Miller E.K., and Cohen J.D. An integrative theory of prefrontal cortex function. Annu. Rev. Neurosci. 24 (2001) 167-202
189. Mirenowicz J., and Schultz W. Importance of unpredictability for reward responses in primate dopamine neurons. J. Neurophysiol. 72 2 (1994) 1024-1027
190. Misane I., Johansson C., and Ögren S.O. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat. Br. J. Pharmacol. 125 3 (1988) 499-509
191. Misane I., and Ögren S.O. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT. Neuropsychopharmacology 22 2 (2000) 168-190
192. Misane I., and Ögren S.O. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT. Neuropsychopharmacology 22 2 (2002) 168-190
193. Mishkin M., Malamut B., and Bachevalier J. Memories and habits: two neuronal systems. In: McGrawHill J.L., and Weinberger N.M. (Eds). Neurobiology of Human Learning and Memory (1984), The Guilford press, New York 65-87
194. Mitchell E.S., and Neumaier J.F. 5-HT6 receptors: a novel target for cognitive enhancement. Pharmacol. Ther. 108 3 (2005) 320-333
195. Morrow B.A., Elsworth J.D., Rasmusson A.M., and Roth R.H. The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neuroscience 92 2 (1999) 553-564
196. Müller U., von Cramon D.Y., and Pollmann S. D1- versus D2-receptor modulation of visuospatial working memory in humans. J. Neurosci. 18 7 (1998) 2720-2728
197. Murphy D.L., Andrews A.M., Wichems C.H., Li Q., Tohoda M., and Greenberg B. Brain serotonin neurotransmission: an overview and update with emphasis on serotonin system heterogeneity, multiple receptors, interactions with other neurotransmitter systems, and consequent implications for understanding the actions of serotonergic drugs. J. Clin. Psychiatry 59 Suppl. 15 (1998) 4-12
198. Murtha J.E.S., and Pappas A.B. Neurochemical, histopatological and mnemonic effect of combined lesions of the medial septal and serotonin afferents to the hippocampus. Brain Res. 651 1-2 (1994) 16-26
199. Naghdi N., and Harooni H.E. The effect of intrahippocampal injections of ritanserin (5HT2A/2C antagonist) and granisetron (5HT3 antagonist) on learning as assessed in the spatial version of the water maze. Behav. Brain Res. 157 2 (2005) 205-210
200. Nakazato T. Striatal dopamine release in the rat during a cued lever-press task for food reward and the development of changes over time measured using high-speed voltammetry. Exp. Brain. Res. 166 1 (2005) 137-146
201. Nayak S.V., Rondé P., Spier A.D., Lummis S.C., and Nichols R.A. Nicotinic receptors co-localize with 5-HT(3) serotonin receptors on striatal nerve terminals. Neuropharmacology 39 13 (2000) 2681-2690
202. Nedergaard S., Bolam J.P., and Greenfield S.A. Facilitation of a dendritic calcium conductance by 5-hydroxytriptamine in the substantia nigra. Nature 333 6169 (1988) 174-177
203. Normile H.J., Jenden D.J., Khun D.M., Wolf W.A., and Altman H.J. Effects of combined serotonin depletion and lesions of the nucleus basalis magnocellularis on acquisition of a complex spatial discrimination task in the rat. Brain Res. 563 1-2 (1990) 245-250
204. Ögren S.O. Central serotonin neurons in avoidance learning: interactions with noradrenaline and dopamine neurons. Pharmacol. Biochem. Behav. 23 1 (1985) 107-123
205. Ögren S.O. Analysis of the avoidance learning deficit induced by the serotonin releasing compound p-chloroamphetamine. Brain Res. Bull. 16 5 (1986) 645-660
206. Ögren S.O. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT. Neuropsychopharmacology 22 2 (2000) 168-190
207. O'Hearn E., and Molliver M.E. Organization of raphe-cortical projections in rat: a quantitative retrograde study. Brain Res. Bull. 13 6 (1984) 709-726
208. Olvera-Cortés E., Brarajas-pérez M., Morales Villagrán A., and González-Burgos I. Cerebral serotonin depletion induces egocentric learning improvement in developing rats. Neurosci. Lett. 313 1-2 (2001) 29-32
209. Packard M.G., and Knowlton B.J. Learning and memory functions of the basal ganglia. Annu. Rev. Neurosci. 25 (2002) 563-593
210. Packard M.G., and McGaugh J.L. Quinpirole and d-amphetamine administration post-training enhances memory on spatial and cued discriminations in a water maze. Psychobiology 22 (1994) 54-60
211. Packard M.G., and McGaugh J.L. Inactivation of hippocampus or caudate nucleus with lidocaine differentially affects expression of place and response learning. Neurobiol. Learn. Mem. 65 1 (1996) 65-72
212. Packard M.G., and White N.M. Dissociation of hippocampus and caudate nucleus memory systems by post-training intracerebral injection of dopamine agonist. Behav. Neurosci. 105 2 (1991) 295-306
213. Palfreyman M.G., Schmidt C.J., Sorensen S.M., Dudley M.W., Kehne J.H., Moser P., Gittos M.W., and Carr A.A. Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function. Psychopharmacol. (Berl.) 112 Suppl. 1 (1993) S60-S67
214. Parent A., Descarries L., and Beaudet A. Organization of ascending serotonin systems in the adult rat brain. A radioautographic study after intraventricular administration of [3H]5-hydroxytryptamine. Neuroscience 6 (1981) 115-138
215. Pasquier D.A., Kemper T.L., Forbes W.B., and Morgane P.J. Dorsal raphe, substantia nigra and locus coeruleus: interconnections with each other and the neostriatum. Brain Res. Bull. 2 5 (1977) 323-339
216. Paulus W., and Jellinger K. The neuropathological basis of different clinical subgroups of Parkinson's disease. J. Neuropathol. Exp. Neurol. 50 6 (1991) 743-755
217. Pavese N., Evans A.H., Tay Y.F., Hotton G., Brooks D.J., Lees A.J., and Piccini P. Clinical correlates of levodopa-induced dopamine release in Parkinson's disease: a PET study. Neurology 67 9 (2006) 1612-1617
218. Pehek E.A., McFarlane H.G., Maguschak K., Price B., and Pluto C.P. M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex. Brain Res. 888 1 (2001) 51-59
219. Pehek E.A., Nocjar C., Roth B.L., Byrd T.A., and Mabrouk O.S. Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology 31 2 (2006) 265-277
220. Pérez-vega M.I., Feria-Velásco A., and González-Burgos I. Prefrontocortical serotonin depletion results in plastics changes of prefrontocortical pyramidal neurons, underlying greater efficiency of short-term memory. Brain Res. Bull. 53 3 (2000) 291-300
221. Peyron C., Petit J.M., Rampon C., Jouvet M., and Luppi P.H. Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods. Neuroscience 82 2 (1998) 443-468
222. Pierucci M., Di Matteo V., and Espósito E. Stimulation of serotonin2C receptors blocks the hyperactivation of midbrain dopamine neurons induced by nicotine administration. J. Pharmacol. Exp. Ther. 3009 1 (2004) 109-118
223. Pizzagalli D.A., Evins A.E., Schetter E.C., Frank M.J., Pajtas P.E., Santesso D.L., and Culhane M. Single dose of dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness. Psychopharmacol. (Berl.) 196 2 (2008) 221-232
224. Plasse G., Meerker D.T.J., Lieben C.K.J., Blokland A., and Feenstra M.G.P. Lack of evidence for reduced prefrontal cortical serotonin and dopamine efflux after acute tryptophan depletion. Psychopharmacol. (Berl.) 195 3 (2007) 377-385
225. Pompeiano M., Palacios J.M., and Mengod G. Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J. Neurosci. 12 2 (1992) 440-453
226. Ponnusamy R., Nissin H.A., and Barad M. Systemic blockade of D2-like dopamine receptors facilitate extinction of conditioned fear in mice. Learn. Mem. 12 4 (2005) 399-406
227. Porras G., De Deurwaerdere P., Moison D., and Spampinato U. Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum. Eur. J. Neurosci. 17 4 (2003) 771-781
228. Prado-Alcala R.A., Grinberg Z.J., Arditti Z.L., Garcia M.M., Prieto H.G., and Brust-Carmona H. Learning deficits produced by chronic and reversible lesions of the corpus striatum in rats. Physiol. Behav. 15 3 (1975) 283-287
229. Prado-Alcalá R.A., Ruiloba M.I., Rubio L., Solana-Figueroa R., Medina C., Salado-Castillo R., and Quirarte G.L. Regional infusions of serotonin into the striatum and memory consolidation. Synapse 47 3 (2003) 169-175
230. Prado-Alcalá R.A., Solana-Figueroa R., Galindo L.E., Medina A.C., and Quitarte G.L. Blockade of striatal 5-HT2 receptors produces retrograde amnesia in rats. Life Sci. 74 4 (2003) 481-488
231. Quednow B.B., Jessen F., Kuhn K.U., Maier W., Daum I., and Wagner M. Memory deficits in abstinent NDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction. J. Neuropsychopharmacol. 20 3 (2006) 373-384
232. Ramírez M.J., Cenarruzabeitia E., Lasheras B., and Del Rio J. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices. Brain Res. 757 1 (1997) 17-23
233. Rampello L., Chiechio S., Rafaele R.R., Vecchio I., and Nicoletti F. The SSRI citalopram improves bradykinesia in patients with Parkinson's disease treated with L-Dopa. Clin. Neuropharmacol. 25 1 (2002) 21-24
234. Rebec G.V., Christensen J.R., Guerra C., and Bardo M.T. Regional and temporal differences in real-time dopamine efflux in the nucleus accumbens during free-choice novelty. Brain Res. 776 1-2 (1997) 61-67
235. Reneman L., Booij J., Schmand B., Van der Brink W., and Gunning B. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology 148 3 (2000) 322-324
236. Richter-Levin G., and Segal M. Spatial performance is severely impaired in rats with combined reduction of serotonergic and cholinergic transmission. Brain Res. 477 1-2 (1989) 404-407
237. Riedel W.L., Klaannen T., Deutz N.E.P., Van Someten A., and Van Praag H.R. Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacol. (Berl.) 141 4 (1999) 362-369
238. Robbins T.W., and Roberts A.C. Differential regulation of fronto-executive function by the monoamines and acetylcholine. Cereb. Cortex. Suppl. 1 (2007) i151-i160
239. Robinson D.L., Phillips P.E., Budygin E.A., Trafton B.J., Garris P.A., and Wightman R.M. Sub-second changes in accumbal dopamine during sexual behavior in male rats. Neuroreport 12 11 (2001) 2549-2552
240. Roitman M.F., Stuber G.D., Phillips P.E., Wightmanm R.M., and Carelli R.M. Dopamine operates as a subsecond modulator of food seeking. J. Neurosci. 24 6 (2004) 1265-1271
241. Rondé P., and Nichols R.A. High calcium permeability of serotonin 5-HT3 receptors on presynaptic nerve terminals from rat striatum. J. Neurochem. 70 3 (1998) 1094-1103
242. Roth B.L., Craigo S.C., Choudhary M.S., Uluer A., Monsma Jr. F.J., Shen Y., Meltzer H.Y., and Sibley D.R. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther. 268 3 (1994) 1403-1410
243. Ruotsalainen S., McDonald E., Koivisto E., Stefanski R., Haapalinna A., Riekkinen Jr. P., and Sirviö J. 5-HT1A receptor agonist (8-OH-DPAT) and 5-HT2 receptor agonist (DOI) disrupt the non-cognitive performance of rats in a working memory task. J. Psychopharmacol. 12 2 (1998) 177-185
244. Sakai K., Salvert D., Touret M., and Jouvet M. Afferent connections of the nucleus raphe dorsalis in the cat as visualized by the horseradish peroxidase technique. Brain Res. 137 1 (1977) 11-35
245. Salomone J.D., Cousins M.S., and Snyder B.J. Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis. Neurosci. Biobehav. Rev. 21 3 (1997) 341-359
246. Sawaguchi T., and Goldman-Rakic P.S. D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251 4996 (1991) 947-950
247. Scatton B., Javoy-Agid F., Rouquier L., Dubois B., and Agid Y. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res. 275 2 (1983) 321-328
248. Schmitt J.A., Jorissen B.L., Sobczak S., van Boxtel M.P., Hogervorst E., Deutz N.E., and Riedel W.J. Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers. J. Psychopharmacol. 14 1 (2000) 21-29
249. Scholes K.E., Harrison B.J., O′Neurill B.V., Leung S., Croft R.J., Pipingas A., Phan K.L., and Nathan P.J. Acute serotonin and dopamine depletion improves attentional control: findings from the stroop task. Neuropsychopharmacology 32 7 (2007) 1600-1610
250. Scholtissen B., Verhey F.R.J., Adam J.J., Prickaerts J., and Leentjens A.F. Effects of acute tryptophan depletion on cognition, memory and motor performance in Parkinson's disease. J. Neurol. Sci. 248 1-2 (2006) 259-265
251. Schultz W. Dopamine neurons and their role in reward mechanisms. Curr. Opin. Neurobiol. 7 2 (1997) 191-197
252. Schultz W. Predictable reward signal of dopamine neurons. J. Neurophysiol. 80 1 (1998) 1-27
253. Schultz W., Dayan P., and Montague P.R. A neural substrate of prediction and reward. Science 275 5306 (1997) 1593-1599
254. Seamans J.K., Durstewitz D., Christie B.R., Stevens C.F., and Sejnowski T.J. Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. Proc. Natl. Acad. Sci. U.S.A. 98 1 (2001) 301-306
255. Seamans J.K., Gorelova N., Durstewitz D., and Yang C.R. Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J. Neurosci. 21 10 (2001) 3628-3638
256. Seamans J.K., and Yang C.R. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog. Neurobiol. 74 1 (2004) 1-58
257. Sesack S.R., and Carr D.B. Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia. Physiol. Behav. 77 4-5 (2002) 513-517
258. Sesack S.R., and Pickel V.M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J. Comp. Neurol. 320 2 (1992) 145-160
259. Shapovalova K.B., and Kamkina Y.V. Motor and cognitive functions of the neostriatum during bilateral blockade of its dopamine receptors. Neurosci. Behav. Physiol. 38 1 (2008) 71-79
260. Simon H., Scatton B., and Moal M.L. Dopaminergic A10 neurons are involved in cognitive functions. Neurosci. Lett. 15 2-3 (1980) 319-324
261. Sleight A.J., Consolo S., Martin J.R., Boes M., Boess F.G., Bentley J.C., and Bourson A. 5-HT6 receptors: functional correlates and potential therapeutic indications. Behav. Pharmacol. 10 (1999) S86
262. Smith A.D., Smith D.L., Zigmond M.J., Amalric M., and Koob G.F. Differential effects of dopamine receptors subtype blockade on performance of rats in a reaction-time paradigm. Psychopharmacology 148 4 (2000) 355-360
263. Soghomonian J.J., Descarries L., and Watkins K.C. Serotonin innervation in adult rat neostriatum II ultrastructural features: a radioautographic and immunocytochemical study. Brain Res. 481 1 (1989) 67-86
264. Solana-Figueroa R., Salado-Castillo R., Galindo L.E., Quitarte G.L., and Prado-Alcalá R.A. Effects of pretraining with intrastriatal administration of p-chloroamphetamine on inhibitory avoidance. Neurobiol. Learn. Mem. 78 1 (2002) 178-185
265. Schreiber R., Vivian J., Hedley L., Szczepanski K., Secchi R.L., Zuzow M., van Laarhoven S., Moreau J.-L., Martin J.R., and Blokland A. Effects of the novel 5-HT6 receptor antagonist RO4368554 in rat model for cognition and sensorimotor gating. Eur. Neuropsychopharmacol 17 (2007) 277-288
266. Staübli U., and Xu B. Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory, and LTP induction in the freely moving rat. J. Neurosci. 15 3, pt 2 (1995) 2445-2452
267. Stone J.M., and Pilowsky L.S. Novel targets for drugs in schizophrenia. CNS Neurol. Disord. Drug Targets 6 4 (2007) 265-272
268. Stoof J.C., and Kebabian J.W. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294 5839 (1981) 366-368
269. Stuchlik A. Further study of the effects of dopaminergic D1 drugs on place avoidance behavior using pretraining: some negative evidence. Behav. Brain Res. 178 1 (2007) 47-52
270. Stuchlik A., Rehakova L., Telensky P., and Vales K. Morris water maze learning in Long-Evans rats is differentially affected by blockade of D1-like and D2-like dopamine receptors. Neurosci. Lett. 422 3 (2007) 169-174
271. Stuchlik A., Rezacova L., Vales K., Bubenikova V., and Kubuk S. Application of a novel allothetic place avoidance task (AAAPA) in testing a pharmacological model of psychosis in rats: comparison with the Morris water maze. Neurosci. Lett. 366 2 (2004) 162-166
272. Stuchlik A., and Vales K. Effect of dopamine D1 receptor antagonist SCH23390 and D1 agonist A77636 on active allothetic place avoidance, a spatial cognition task. Behav. Brain Res. 172 2 (2006) 250-255
273. Sutton M.A., Rolfe N.G., and Beninger R.J. Biphasic effects of 7-OH-DPAT on the acquisition of responding for conditioned reward in rats. Pharmacol. Biochem. Behav. 69 1-2 (2001) 195-200
274. Suzuki T., Miura M., Nishimura K., and Aosaki T. Dopamine-dependent synaptic plasticity in the striatal cholinergic interneurons. J. Neurosci. 21 17 (2001) 6492-6501
275. Tanila H., Björklund M., and Riekkinen Jr. P. Cognitive changes in mice following moderate MPTP exposure. Brain Res. Bull. 45 6 (1998) 577-582
276. Tanaka H., Kannari K., Maeda T., Tomiyama M., Suda T., and Matsunaga M. Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats. Neuroreport 10 3 (1999) 631-634
277. Tinaz S., Schendan H.E., Schon K., and Stern C.E. Evidence for the importance of basal ganglia output nuclei in semantic event sequencing: an fMRI study. Brain Res. 1067 1 (2006) 239-249
278. Trantham-Davidson, H., Kröner, S. and Seamans, J.K. (2008) Dopamine modulation of prefrontal cortex interneurons occurs independently of DARPP-32. Cereb. Cortex., 0: bhm133v1.
279. Trantham-Davidson H., Neely L.C., Lavin A., and Seamans J.K. Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex. J. Neurosci. 24 47 (2004) 10652-10659
280. Trimmer B.A. The messenger is not the message; or is it?. In: Katz P.S. (Ed). Beyond Neurotransmission (1999), Oxford University Press, New York 29-82
281. Truffinet P., Tamminga C., Fabre L.F., Meltzr H.Y., Riviere M.-E., and Papillon-Downey C. Placebo-controlled study of the D4/5-HT24 antagonist fananserin in the treatment of schizophrenia. Am. J. Psychiatry 156 3 (1999) 418-425
282. Tseng K.Y., and O'Donnell P. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. J. Neurosci. 44 5 (2004) 1526-1539
283. Ugedo L., Grenhoff J., and Svenson T.H. Ritanserin, 5-HT2 receptor antagonist, activate midbrain dopamine neurons by blocking serotonin inhibition. Psychopharmacol. (Berl.) 98 1 (1989) 45-50
284. Vales K., and Struchlik A. A central muscarinic blockade interferes with learning and retrieval of the active allothetic place avoidance task despite spatial pretraining. Behav. Brain Res. 161 (2005) 238-244
285. Vertes R.P. Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse 51 1 (2004) 32-58
286. Ward J., Hall K., and Haslam C. Patterns of memory dysfunction in current and 2-year abstinent NDMA users. J. Clin. Exp. Neuropsychol. 28 3 (2006) 306-324
287. Ward B.O., Wilkinson L.S., Robbins T.W., and Everitt B.J. Forebrain serotonin depletion facilitates the acquisition and performance of a conditional visual discrimination task in rats. Behav. Brain. Res. 100 1-2 (1999) 51-65
288. Watanabe K., and Kimura M. Dopamine receptor-mediated mechanisms involved in the expression of learned activity of primate striatal neurons. J. Neurophysiol. 79 5 (1998) 2568-2580
289. Wenk G., Hughey D., Boundy V., Kim A., Walker L., and Olton D. Neurotransmitters and memory: role of cholinergic, serotonergic, and noradrenergic systems. Behav. Neurosci. 101 3 (1987) 325-332
290. Werkman T.R., Glennon J.C., Wadman W.J., and McCreary A.C. Dopamine receptor pharmacology: interactions with serotonin receptors and significance for the aetiology and treatment of schizophrenia. CNS Neurol. Disord. Drug Targ. 5 1 (2006) 3-23
291. West A.R., and Grace A.A. Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis. J. Neurosci. 22 1 (2002) 294-304
292. White N.M., Packard M.G., and Seamans J. Memory enhancement by post-training peripheral administration of low doses of dopamine agonists: possible autoreceptor effect. Behav. Neural Biol. 59 3 (1993) 230-241
293. White N.M., and Salinas J.A. Mnemonic functions of dorsal striatum and hippocampus in aversive conditioning. Behav. Brain Res. 142 1-2 (2003) 99-107
294. Willins D.L., and Meltzer H.Y. Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens. Brain Res. 781 1-2 (1998) 291-299
295. Wightman R.M., and Robinson D.L. Transient changes in mesolimbic dopamine and their association with 'reward'. J. Neurochem. 82 4 (2002) 721-735
296. Wilkerson A., and Levin E.D. Ventral hippocampal dopamine D1 and D2 systems and spatial working memory in rats. Neuroscience 89 3 (1999) 743-749
297. Wilson, Ch.J. (1998) Basal ganglia. In Shepherd, G. M (Ed.), The Synaptic Organization of the Brain, Fourth edn. Chap. 9, pp. 329-375.
298. Winocur G. Functional dissociation within the caudate nucleus of rats. J. Comp. Physiol. Psychol. 86 3 (1974) 432-439
299. Winterer G., and Weinberger D.R. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci. 27 11 (2004) 683-690
300. Wolf M.E., Deutch A.Y., and Roth R.H. Pharmacology of central dopaminergic neuron. In: Henn F.A., and DeLisi L.E. (Eds). Handbook of Neurochemistry and Neuropharmacology of Schizophrenia Vol. 2., Chap. 7 (1987), Elsevier Science Publishers BV, New York 101-147
301. Wolterink G., Phillips G., Cador M., Donselaar-Wolterink I., Robbins T.W., and Everitt B.J. Relative roles of ventral striatal D1 and D2 dopamine receptors in responding with conditioned reinforcement. Psychopharmacol. (Berl.) 110 3 (1993) 355-364
302. Wood M.D., Reavill C., Trail B., Wilson A., Stean T., Kennett G.A., Lightowler S., Blackburn T.P., Thomas D., Gager T.L., Riley G., Holland V., Bromidge S.M., Forbes I.T., and Middlemiss D.N. SB-243213, a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety. Neuropharmacology 41 2 (2001) 186-199
303. Yin H.H., Knowlton B.J., and Balleine B.W. Lesions of the dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning. Eur. J. Neurosci. 19 1 (2004) 181-189
304. Yu L., and Liao P.C. Estrogen and progesterone distinctively modulate methamphetamine-induced dopamine and serotonin depletions in C57BL/6J mice. J. Neural. Transm. 107 10 (2000) 1139-1147
305. Zahrt J., Taylor J.R., Mathew R.G., and Arnsten A.F. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J. Neurosci. 17 21 (1997) 8528-8535
306. Zakzanis K.K., Campbell Z., and Jovanovski D. The neuropsychology of ecstasy (NDMA) use: a review. Hum. Psychopharmacol. 22 7 (2007) 427-435
307. Zheng P., Zhang X.X., Bunney B.S., and Shi W.X. Opposite modulation of cortical N-methyl-d-aspartate receptor-mediated responses by low and high concentrations of dopamine. Neuroscience 91 2 (1999) 527-535
308. Zhou F.M., and Hablitz J.J. Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex. J. Neurophysiol. 82 6 (1999) 2989-2999